Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich Plasma in Pilonidal Sinus Surgery
NCT07567586Completed
- Sponsor
- Fayoum University
- Start
- Mar 2023
- Primary completion
- Mar 2025
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised, open-label trial of platelet-rich plasma in pilonidal sinus disease (2 arms), sponsored by Fayoum University. Primary endpoint: Incidence of healing rate of the wound (dehiscence) at 1 month. Started Mar 2023; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
pilonidal sinus disease
Beyond the preview
Go deeper on NCT07567586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07567586.